Results 201 to 210 of about 203,049 (341)

Left Ventricular Assist Device-Associated Infections: Case Series

Journal of Global Antimicrobial Resistance
AIM: We evaluate the epidemiological, laboratory, and clinical data of left ventricular assist device (LVAD)-associated infections diagnosed based on clinical evaluation, imaging studies, and microbiologic tests.
Bahar Busra Sivrikaya, Ozgur Gunal
doaj  

A PORTABLE PNEUMATIC BIVENTRICULAR DRIVER FOR THE THORATEC VENTRICULAR ASSIST DEVICE

, 1997
David J. Farrar, Katherin Buck, JACK H. COULTER   +2 more
openalex   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Left ventricular assist device exchanges: A safe and effective strategy in the era of limited organ availability. [PDF]

Int J Artif Organs
Nair N, Nguyen K, Du D, Mahesh A, Soleimani B, Mahesh B.   +5 more
europepmc   +1 more source

Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy [PDF]

, 2000
Roland Hetzer, Johannes H. Müller, Yuguo Weng, Matthias Loebe, Gert Wallukat   +4 more
openalex   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Totally implantable intrathoracic ventricular assist device

, 1996
Tofy Mussivand, Roy G. Masters, Paul Hendry, Wilbert J. Keon   +3 more
openalex   +1 more source

Single-center experience with the thoratec ventricular assist device [PDF]

, 2000
Reiner Körfer, Aly El‐Banayosy, Latif Arusoglu, Kazutomo Minami, Michael Körner, L. Kizner, O. Fey, U. Schütt, Michiel Morshuis, Herbert Posival   +9 more
openalex   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Candidemia in Left Ventricular Assist Device Recipients: Incidence, Risk Factors, and Outcomes. [PDF]

Open Forum Infect Dis
Anderson R, Pouch S, Busch L, Hayes T, Sennhauser S, Chan JL, Eichenberger EM.   +6 more
europepmc   +1 more source